Affinity proteomics discovers decreased levels of AMFR in plasma from Osteoporosis patients

Proteomics - Clinical Applications

Volumn 10, Issue 6, 2016, Pages 681-690

  Qundos, Ulrika ^a   Drobin, Kimi ^a   Mattsson, Cecilia ^a   Hong, Mun Gwan ^a   Sjöberg, Ronald ^a   Forsström, Björn ^a   Solomon, David ^a   Uhlén, Mathias ^a   Nilsson, Peter ^a   Michaëlsson, Karl ^b   Schwenk, Jochen M ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antibody bead arrays; Biomarker discovery; Osteoporosis; Plasma

Indexed keywords

AUTOCRINE MOTILITY FACTOR RECEPTOR; AUTOCRINE MOTILITY FACTOR RECEPTOR ANTIBODY; PEPTIDE; PLASMA PROTEIN; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; AMFR PROTEIN, HUMAN; ANTIBODY; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; AUTOCRINE MOTILITY FACTOR RECEPTOR BLOOD LEVEL; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN MICROARRAY; PROTEOMICS; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; BLOOD; CASE CONTROL STUDY; CHEMISTRY; GENE EXPRESSION; GENETICS; MIDDLE AGED; PROCEDURES;

AGED; AMINO ACID SEQUENCE; ANTIBODIES; ANTIBODY SPECIFICITY; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; RECEPTORS, AUTOCRINE MOTILITY FACTOR;

EID: 84928139985     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400167     Document Type: Article

References (32)

1. Warensjo, E., Byberg, L., Melhus, H., Gedeborg, R. et al., Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ 2011, 342, d1473.
2. Bhattacharyya, S., Siegel, E. R., Achenbach, S. J., Khosla, S., Suva, L. J., Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women. J. Bone Min. Res. 2008, 23, 1106-1117.
3. Hernlund, E., Svedbom, A., Ivergard, M., Compston, J. et al., Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch. Osteoporosis 2013, 8, 136.
4. Aaseth, J., Boivin, G., Andersen, O., Osteoporosis and trace elements-an overview. J. Trace Elements Med. Biol. 2012, 26, 149-152.
5. Landegren, U., Vanelid, J., Hammond, M., Nong, R. Y. et al., Opportunities for sensitive plasma proteome analysis. Anal. Chem. 2012, 84, 1824-1830.
6. Ayoglu, B., Haggmark, A., Neiman, M., Igel, U. et al., Systematic antibody and antigen-based proteomic profiling with microarrays. Exp. Rev. Mol. Diagn. 2011, 11, 219-234.
7. Bystrom, S., Ayoglu, B., Haggmark, A., Mitsios, N. et al., Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis. J. Proteome Res. 2014, 13, 4607-4619.
8. Stoevesandt, O., Taussig, M. J., Affinity proteomics: the role of specific binding reagents in human proteome analysis. Exp. Rev. Proteomics 2012, 9, 401-414.
9. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E. et al., Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28, 1248-1250.
10. Snellman, G., Byberg, L., Lemming, E. W., Melhus, H. et al., Long-term dietary vitamin D intake and risk of fracture and osteoporosis: a longitudinal cohort study of Swedish middle-aged and elderly women. J. Clin. Endocrinol. Metab. 2014, 99, 781-790.
11. Michaeelsson, K., Lind, L., Frystyk, J., Flyvbjerg, A. et al., Serum adiponectin in elderly men does not correlate with fracture risk. J. Clin. Endocr. Metab. 2008, 93, 4041-4047.
12. Haggmark, A., Bystrom, S., Ayoglu, B., Qundos, U. et al., Antibody-based profiling of cerebrospinal fluid within multiple sclerosis. Proteomics 2013, 13, 2256-2267.
13. Schwenk, J. M., Igel, U., Neiman, M., Langen, H. et al., Toward next generation plasma profiling via heat-induced epitope retrieval and array-based assays. Mol. Cell Proteomics 2010, 9, 2497-2507.
14. Drobin, K., Nilsson, P., Schwenk, J. M., Highly multiplexed antibody suspension bead arrays for plasma protein profiling. Methods Mol. Biol. 2013, 1023, 137-145.
15. Algenas, C., Agaton, C., Fagerberg, L., Asplund, A. et al., Antibody performance in western blot applications is context dependent. Biotechnol. J. 2014, 9, 435-445.
16. Eriksson, C., Schwenk, J. M., Sjoberg, A., Hober, S., Affibody molecule-mediated depletion of HSA and IgG using different buffer compositions: a 15 min protocol for parallel processing of 1-48 samples. Biotechnol. Appl. Bioc. 2010, 56, 49-57.
17. Forsstrom, B., Axnas, B. B., Stengele, K. P., Buhler, J. et al., Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays. Mol. Cell Proteomics 2014, 13, 1585-1597.
18. Ayoglu, B., Haggmark, A., Khademi, M., Olsson, T. et al., Autoantibody profiling in multiple sclerosis using arrays of human protein fragments. Mol. Cell Proteomics 2013, 12, 2657-2672.
19. Sjoberg, R., Sundberg, M., Gundberg, A., Sivertsson, A. et al., Validation of affinity reagents using antigen microarrays. N. Biotechnol. 2012, 29, 555-563.
20. Ihaka, R., Gentleman, R., R: a language for data analysis and graphics. J. Comput. Graph. Stat. 1996, 5, 299-314.
21. Hubert, M., Rousseeuw, P. J., Vanden Branden, K., ROBPCA: a new approach to robust principal component analysis. Technometrics 2005, 47, 64-79.
22. Kato, B. S., Nicholson, G., Neiman, M., Rantalainen, M. et al., Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model. Proteome Sci. 2011, 9, 73.
23. Tibshirani, R., Regression shrinkage and selection via the Lasso. J. Roy. Stat. Soc. B Met. 1996, 58, 267-288.
24. Estrada, K., Styrkarsdottir, U., Evangelou, E., Hsu, Y. H. et al., Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat. Genet. 2012, 44, 491-+.
25. Rivadeneira, F., Styrkarsdottir, U., Estrada, K., Halldorsson, B. V. et al., Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat. Genet. 2009, 41, 1199-U1158.
26. Fagerberg, L., Hallstrom, B. M., Oksvold, P., Kampf, C. et al., Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell Proteomics 2014, 13, 397-406.
27. Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R. et al., The genotype-tissue expression (GTEx) project. Nat. Genet. 2013, 45, 580-585.
28. Nabi, I. R., Watanabe, H., Raz, A., Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res. 1990, 50, 409-414.
29. Chiu, C. G., St-Pierre, P., Nabi, I. R., Wiseman, S. M., Autocrine motility factor receptor: a clinical review. Exp. Rev. Anticancer 2008, 8, 207-217.
30. Guenther, R., Krenn, V., Morawietz, L., Dankof, A. et al., Giant cell tumors of the bone: Molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR. Pathol. Res. Pract. 2005, 201, 649-663.
31. Ayoglu, B., Chaouch, A., Lochmuller, H., Politano, L. et al., Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies. EMBO Mol. Med. 2014, 6, 918-936.
32. Bachmann, J., Burte, F., Pramana, S., Conte, I. et al., Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria. PLoS Pathog. 2014, 10, e1004038.